186 related articles for article (PubMed ID: 35387563)
61. Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells.
Yang MH; Jung SH; Um JY; Kumar AP; Sethi G; Ahn KS
Life Sci; 2022 Apr; 295():120395. PubMed ID: 35181309
[TBL] [Abstract][Full Text] [Related]
62. TIPE2 Overexpression Suppresses the Proliferation, Migration, and Invasion in Prostate Cancer Cells by Inhibiting PI3K/Akt Signaling Pathway.
Lu Q; Liu Z; Li Z; Chen J; Liao Z; Wu WR; Li YW
Oncol Res; 2016; 24(5):305-313. PubMed ID: 27712587
[TBL] [Abstract][Full Text] [Related]
63. Salidroside suppresses proliferation and migration in prostate cancer via the PI3K/AKT pathway.
Liu RH; Ma TF; Yang Q; Xiao WC; Yin L; Yin M; Zhang JS; Wang CH
Cancer Biomark; 2023; 38(3):321-332. PubMed ID: 37545219
[TBL] [Abstract][Full Text] [Related]
64. Fraxetin protects rat brains from the cerebral stroke
Cui Y; Liu M; Zuo L; Wang H; Liu J
Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):400-409. PubMed ID: 35285387
[TBL] [Abstract][Full Text] [Related]
65. LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway.
Abuduer M; A EZG
Tissue Cell; 2021 Aug; 71():101579. PubMed ID: 34171521
[TBL] [Abstract][Full Text] [Related]
66. LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway.
Li Z; Jin Q; Sun Y
J Clin Lab Anal; 2022 Jul; 36(7):e24406. PubMed ID: 35588431
[TBL] [Abstract][Full Text] [Related]
67. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
Zhang J; Yang Y; Dong Y; Liu C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
[TBL] [Abstract][Full Text] [Related]
68. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
Liu K; Xue B; Bai G; Zhang W
Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
[TBL] [Abstract][Full Text] [Related]
69. Psoralidin, an herbal molecule, inhibits phosphatidylinositol 3-kinase-mediated Akt signaling in androgen-independent prostate cancer cells.
Kumar R; Srinivasan S; Koduru S; Pahari P; Rohr J; Kyprianou N; Damodaran C
Cancer Prev Res (Phila); 2009 Mar; 2(3):234-43. PubMed ID: 19223576
[TBL] [Abstract][Full Text] [Related]
70. Bornyl acetate extracted from Sharen () inhibits proliferation, invasion and induces apoptosis by suppressing phosphatidylinositol-3-kinase/protein kinase B signaling in colorectal cancer.
Xiaohua LI; Zhihang D; Jianjun Y; Yongyu Z; Yihang LI; Shifang L; Qu N; Depo Y; Lixia Z
J Tradit Chin Med; 2023 Oct; 43(6):1081-1091. PubMed ID: 37946470
[TBL] [Abstract][Full Text] [Related]
71. Palmitic acid inhibits prostate cancer cell proliferation and metastasis by suppressing the PI3K/Akt pathway.
Zhu S; Jiao W; Xu Y; Hou L; Li H; Shao J; Zhang X; Wang R; Kong D
Life Sci; 2021 Dec; 286():120046. PubMed ID: 34653428
[TBL] [Abstract][Full Text] [Related]
72. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Fujita S
Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110
[TBL] [Abstract][Full Text] [Related]
73. Synergistic anticancer efficacy of MEK inhibition and dual PI3K/mTOR inhibition in castration-resistant prostate cancer.
Park H; Kim Y; Sul JW; Jeong IG; Yi HJ; Ahn JB; Kang JS; Yun J; Hwang JJ; Kim CS
Prostate; 2015 Nov; 75(15):1747-59. PubMed ID: 26250606
[TBL] [Abstract][Full Text] [Related]
74. Anlotinib inhibits the proliferation and induces apoptosis by inactivating the AKT pathway in androgen receptor-negative prostate cancer cells.
Xu Y; Zheng J; Ye ZY
Neoplasma; 2022 Sep; 69(5):1119-1128. PubMed ID: 36004650
[TBL] [Abstract][Full Text] [Related]
75. Carvacrol Alleviates Prostate Cancer Cell Proliferation, Migration, and Invasion through Regulation of PI3K/Akt and MAPK Signaling Pathways.
Luo Y; Wu JY; Lu MH; Shi Z; Na N; Di JM
Oxid Med Cell Longev; 2016; 2016():1469693. PubMed ID: 27803760
[TBL] [Abstract][Full Text] [Related]
76. MicroRNA-151 regulates the growth, chemosensitivity and metastasis of human prostate cancer cells by targeting PI3K/AKT.
Chen S; Ke S; Cheng S; Wu T; Yang Y; Liao B
J BUON; 2020; 25(4):2045-2050. PubMed ID: 33099951
[TBL] [Abstract][Full Text] [Related]
77. Apoptosis induction of human prostate carcinoma DU145 cells by diallyl disulfide via modulation of JNK and PI3K/AKT signaling pathways.
Shin DY; Kim GY; Lee JH; Choi BT; Yoo YH; Choi YH
Int J Mol Sci; 2012 Nov; 13(11):14158-71. PubMed ID: 23203057
[TBL] [Abstract][Full Text] [Related]
78. Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway.
Li ZZ; Wang YL; Yu YH; Xing YL; Ji XF
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):105-112. PubMed ID: 30657552
[TBL] [Abstract][Full Text] [Related]
79. In vitro anti-cancer effect of marmesin by suppression of PI3K/Akt pathway in esophagus cancer cells.
Wang Q; Zhong S; Wu H; Wu Q
Esophagus; 2022 Jan; 19(1):163-174. PubMed ID: 34398363
[TBL] [Abstract][Full Text] [Related]
80. Long Non-Coding RNA (lncRNA) Growth Arrest Specific 5 (GAS5) Suppresses Esophageal Squamous Cell Carcinoma Cell Proliferation and Migration by Inactivating Phosphatidylinositol 3-kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
Wang G; Sun J; Zhao H; Li H
Med Sci Monit; 2018 Oct; 24():7689-7696. PubMed ID: 30368517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
